CORONARY ARTERY DISEASE THERAPEUTICS MARKET ANALYSIS

Regional Analysis

Coronary Artery Disease Therapeutics Market Regional Analysis:-

North America is expected to hold dominant position in global coronary artery disease therapeutics market due to high prevalence of coronary artery disease. According to a survey conducted by Centers for disease control and prevention (CDC), in 2015, coronary heart disease kills more than 370,000 people annually in the U.S. out of which more than 92% had chest pain as a major symptom. According to a study conducted by American College of Cardiology, in 2017, more than 790000 people experience heart attack annually in the U.S. out of this around 47% people were reported to have hypertension and around 34% were reported to have high blood pressure. Therefore, high prevalence of chronic diseases are expected to drive growth of this market over the forecast period. Asia Pacific coronary artery disease therapeutics market is projected to witness significant growth due to FDA approvals for generic drugs. For instance, in 2017, Lupin, India-based Company received FDA approval to launch generic version of Nadolol Tablets, indicated for the treatment of hypertension and angina pectoris.

• North America
• Europe
• Latin America
• Asia Pacific
• Middle East
• Africa